“…The circulating RAS components, such as AngII and Renin, decrease with age [ 30 , 31 , 32 , 33 ]. In contrast, the expression and levels of the pathological tRAS pathway increase with age, as shown in the heart, vasculature, and the brain [ 30 , 31 , 34 , 35 , 36 ]. Angiotensin II, the main effector of tRAS, was shown to promote vascular senescence onset and progression, leading to age-related vascular diseases [ 37 ].…”